Drug intelligence / Profile preview

Hepatalin-S

Development stage
Preclinical
Lead developer
SciMar
Modality
Recombinant Proteins and Enzymes
Administration
Subcutaneous, Intramuscular, Intravenous
01

Overview

Hepatalin-S is a synthetic version of the naturally occurring hormone hepatalin, which is secreted by the liver in response to insulin pulses after a mixed nutrient meal. Unlike insulin, which primarily acts on the liver and adipose tissue to promote fat storage, hepatalin stimulates glucose uptake and glycogen storage specifically in skeletal muscle, heart, and kidney. It does not act on the liver, intestines, or adipocytes. The mechanism of action involves promoting postprandial glucose partitioning into muscle as glycogen rather than into fat stores. Hepatalin-S is being developed for use alone or in combination with insulin for long-term treatment of type 2 diabetes by restoring this physiological balance and improving glycemic control[2][4][5]. Reduced action of endogenous hepatalin leads to postprandial hyperglycemia and compensatory hyperinsulinemia with increased fat deposition; thus, restoring its function may help prevent or reverse prediabetes and type 2 diabetes[2][4].

Brand names
Hepatalin-S
Other names
hepatalin-ssynthetic hepatalin

Beyond the preview

Go deeper on Hepatalin-S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatalin-S.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call